*OBST is registered with the U.S. FDA and NZ Medsafe as a Class I medical device. Individual results vary. This is not FDA or Medsafe approval or endorsement.
Redefining Recovery. Restoring Balance.
OptiRTP delivers Optimum Bio Sound Therapy (OBST) — a U.S. FDA and NZ Medsafe Registered Class I Medical Device that delivers proprietary ultra-low frequency signals designed to support pain management and daily recovery.*
Used by elite athletes, active individuals, and families seeking a non-invasive, drug-free approach to pain management.
A non-invasive, drug-free approach designed to support pain management and daily recovery
WHAT WE DO
FDA-Registered Medical Device Technology, Developed in New Zealand — Scaling Globally
Optimum Bio Sound Therapy (OBST) is a non-invasive, drug-free medical device that delivers proprietary ultra-low frequency signals through a dedicated tablet and audio delivery system.
These signals work through the body's natural auditory processing—entering as acoustic waves, converting to mechanical vibrations in the ear, and ultimately becoming neural information that reaches the brain. This is the same pathway all sound travels, but OBST's signal architecture has been specifically engineered and refined over a decade of development.
OBST is registered with the U.S. FDA and NZ Medsafe as a Class I medical device designed to support pain management. Currently available in New Zealand and the United States, with planned expansion into additional markets. The signal delivery system streams securely from our data center to your home, requiring no clinic visits or clinical supervision.
At-Home Convenience
Delivered via tablet and audio system, no clinic visits required.
Proprietary Signal Delivery
Ultra-low frequency signals streamed securely to your home.
Non-Invasive Pain Management Support
Designed for use during rest and recovery periods.
FDA-Registered Class I Medical Device
Registered with U.S. FDA and NZ Medsafe.
Trackable Through Wearables
Many subscribers track their data using wearable devices.
HOW IT'S USED
Simple. Powerful. Seamless.
OBST is delivered through a dedicated Apple iPad and OBST-approved Bluetooth earbuds, streaming proprietary ultra-low frequency signals from our secure data center directly to your home.
It's incredibly simple to use. No technical expertise required, no clinic appointments needed—just straightforward home use that fits naturally into your life.
Most subscribers use OBST 2-6 hours daily during rest, sleep, or everyday activities like working, reading, or watching TV. Signal delivery runs quietly in the background—no active participation required. The tablet stays within 2 meters of you, but otherwise, OBST becomes part of your day rather than another task to manage.
Effortless integration. Measurable results.*
OBST is offered on a monthly subscription basis, providing an accessible, continuously supported digital-therapeutic experience within approved indications.
UNDERPINNING SCIENCE
A Decade of Development and Real-World Data Use
OBST delivers proprietary ultra-low frequency signals through a dedicated audio delivery system. These signals enter through the auditory system—where, like all sound, they are converted from acoustic waves to mechanical vibrations and then to neural information processed by the brain.
Our signal architecture is trade-secret protected and has been refined through: 45,000+ hours of research and development, 200,000+ hours of documented subscriber use, and real-world deployment with over 1,100 individuals in New Zealand.
OBST is designed to support pain management and daily recovery. Many subscribers track their progress using personal health monitoring devices such as smart watches and rings, and fitness trackers.
The system is registered with the U.S. FDA and NZ Medsafe as a Class I medical device. We are committed to ongoing research, including a planned clinical study with a U.S. research institution to further evaluate subscriber experiences using validated assessment tools.
BACKGROUND & GROWTH
0
NZ SPORTING REPRESENTATIVES
0
R&D HOURS
0
USER REPORTED SUCCESSES - Figure based on internal surveys and early user-reported outcomes. Individual results vary. No therapeutic claims are implied.
0
YEARS IN DEVELOPMENT
NEWS & UPDATES
February 20, 2026
OptiRTP Deepens Engagement with Evidence-Based Oncology Research Community
OptiRTP Limited is pleased to announce that Sharyn Harper, Chief Operating Officer, has joined the Society for Integrative Oncology (SIO) as a member, with a particular focus on the organisation’s Research Committee.
February 17, 2026
OptiRTP CEO Attends AUT Future of Health Conference
OptiRTP CEO Jon Doherty attended AUT’s Future of Health: Where Aotearoa Leads Next conference, joining leaders from across New Zealand’s health system to discuss the next phase of healthcare innovation.
February 13, 2026
OptiRTP Attends U.S. Consulate Reception Welcoming U.S. SailGP Team
OptiRTP CEO Jon Doherty and Partnerships & Performance Manager Byron Thomas attended a reception on 13 February hosted by U.S. Consul General Melissa Sweeney to welcome the U.S. SailGP Team to Auckland for the second leg of the SailGP 2026 championship.
EXPERIENCE A NEW APPROACH TO RECOVERY
Join the growing community of individuals, households, and recovery professionals who integrate OBST into daily life to support pain management, enhance sleep quality, and improve day-to-day recovery — within approved indications.
----- PRICING INFORMATION -----
Initial Charge: $1,447.50 NZD (incl GST)
This includes:
One-time hardware & software integration fee – $1,350.00 NZD
First month of therapy subscription – $97.50 NZD
The one-time fee covers the required hardware and consumables:
Configured and software-integrated Apple iPad (11th Gen) in a hardened case;
3 pairs of Bluetooth earbuds (for up to 90 hours of Optimum Bio Sound Therapy use each);
1 usb wall charger.
The monthly subscription of $97.50 NZD will continue automatically each month thereafter.
Subscription may be cancelled at any time.
